As I was wandering through and posting recent research, this synthesis of thoughts emerged. Not sure if this is the right section, if not, mods, please feel free to move. Thought I would share my hopes with you: (sorry - the formatting didn't transfer over. I'll do waht I can, but haven't got much energy left. It might be easier to view it here http://www.facebook.com/notes/xmrv-...ould-we-become-a-significant-pla/433892711796 ) ---------------------------------------------------------------------------------- The idea that Canada may be ready to join in XMRV ME/CFS research to a significant level is pure inference, speculation and hope on my part. I first noticed that one of the 3-part package that PNAS published with the FDA/NIH/Harvard paper included a commentary from French researchers and one Canadian, Andrew L Mason from the University of Alberta, and I experienced some patriotic hope that Canada would be entering the research story more fully. This hope is also selfish - I'm hoping for a study I can join that will hopefully fast-track my return to health. In the article, this group states that it is appropriate now to: 1. determine the frequency of MLV infection in patients with CFS. 2. determine the human to human transmission potential 3. start antiretroviral trials 4. determine if XMRV causes ME/CFS And then I noticed that for Dr Stein's new study, trying to determine if XMRV is the cause of ME/CFS, she will be joined by I looked into M Houghton, and found that he is an eminent scientist. He discovered the hepatitus C virus. http://www.cerc.gc.ca/chairholders-titulaires/houghton-eng.shtml And the Canada Excellence Research Chair position brings $10 million a year to his program. http://www.expressnews.ualberta.ca/...wardedfourCanadaExcellenceResearchChairs.aspx This partnership also intrigued me as I remembered lightly researching the Li Ka Shing Institute of Virology in the spring, when word of this study first came out, and hoping that it would engage in ME/CFS research. So I found the article below to refresh my memory. On looking a bit deeper though, A L Mason, of the PNAS article So it seems that the University of Alberta has 2 different incursions into XMRV research 1. A L Mason through the Dept of Medicine and the above funders urging looking at trialling antiretrovirals, and finding causation, transmission and prevalence. I hope that this PNAS article indicates that they are ready to undertake some of these studies themselves. 2. LTyrrell & M Houghton in the Li Ka Shing Institute of Virology at U of A, along with E Stein, seeing if XMRV is causal. And, given the people involved in this study, the words for a preliminary study next month in the news article, the funding that the Chair of Excellence & the Li Ka Shing Institute bring, and the intentions of the U of A and the LKS Institute to be world leaders in 'virus-based diseases' - it seems quite hopeful that further studies into XMRV will start soon out and that U of A may ride the crest of this emerging new disease research field. And then there is Paul Jolicouer, one of Canadas virologists, at the University of Montreal. I found information from 2001 that he was looking at MAIDS After that, all I can track is rumours; rumours that he did a study looking for XMRC in ME/CFS patients last winter that came up negative, and rumours that he was not discouraged and was proceeding with another study. However, when I found his faculty listing, there is no mention of this in his list of current studies. So I am hopeful that the rumours are true, and that with the global race to be the first in on XMRV & family research, P Jolicoeur will get funding to examine XMRV et al and ME/CFS.